Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1994 Jan-Feb;18(1):21-31.
doi: 10.1007/BF00348188.

Hereditary breast cancer and family cancer syndromes

Affiliations
Review

Hereditary breast cancer and family cancer syndromes

H T Lynch et al. World J Surg. 1994 Jan-Feb.

Abstract

Hereditary breast cancer (HBC) shows extant clinical and genetic heterogeneity. Clinically one finds the onset of breast cancer at an early age, an excess of bilaterality, and patterns of multiple primary cancer such as combinations of breast and ovarian carcinoma in the hereditary breast-ovarian cancer (HBOC) syndrome. In addition to HBOC, one sees a variety of putative breast cancer-prone genotypes inclusive of hereditary site-specific breast cancer, and the Li-Fraumeni (SBLA) syndrome that is characterized by cancers involving all three germinal layers including sarcomas, brain tumors, leukemia, lymphoma, and adrenal cortical carcinoma in addition to often markedly early-onset breast cancer. Breast cancer is also associated with autosomal dominantly inherited Cowden's disease and autosomal recessively inherited ataxia-telangiectasia. Examples of pedigrees depicting clinical examples of these several HBC syndromes are presented in order to describe HBC's heterogeneity. The recent identification of the BRCA1 gene in early-onset hereditary site-specific breast cancer and the HBOC syndrome has led to new challenges for the genetic counselor. We review genetic counseling, which embraces surveillance and management recommendations that are responsive to the natural history of HBC and address the concept for future development of centers of expertise for HBC in the interest of improving cancer control.

PubMed Disclaimer

References

    1. Am J Hum Genet. 1993 Apr;52(4):767-76 - PubMed
    1. Ann Surg. 1990 Mar;211(3):250-9 - PubMed
    1. JAMA. 1972 Dec 25;222(13):1631-5 - PubMed
    1. Am J Hum Genet. 1993 Apr;52(4):678-701 - PubMed
    1. Semin Oncol. 1986 Dec;13(4):434-49 - PubMed

LinkOut - more resources